Minerva medica最新文献

筛选
英文 中文
Comparison and analysis of maternal and neonatal outcomes between vaginal delivery and cesarean section. 阴道分娩与剖腹产对产妇和新生儿预后的比较与分析。
Minerva medica Pub Date : 2024-08-05 DOI: 10.23736/S0026-4806.24.09316-9
Ying Huang, Lixiang Feng, Jiaolian Wang, Mengdie Chen
{"title":"Comparison and analysis of maternal and neonatal outcomes between vaginal delivery and cesarean section.","authors":"Ying Huang, Lixiang Feng, Jiaolian Wang, Mengdie Chen","doi":"10.23736/S0026-4806.24.09316-9","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09316-9","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141891451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 25-year-long journey into interventional cardiology: looking back, and rushing forward. 长达 25 年的介入心脏病学之旅:回顾过去,砥砺前行。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-06-13 DOI: 10.23736/S0026-4806.24.09236-X
Nicola Corcione, Paolo Ferraro, Alberto Morello, Michele Cimmino, Michele Albanese, Raffaella Avellino, Sara Turino, Michele Polimeno, Stefano Messina, Gennaro Maresca, Salvatore Giordano, Giuseppe Biondi-Zoccai, Martino Pepe, Arturo Giordano
{"title":"A 25-year-long journey into interventional cardiology: looking back, and rushing forward.","authors":"Nicola Corcione, Paolo Ferraro, Alberto Morello, Michele Cimmino, Michele Albanese, Raffaella Avellino, Sara Turino, Michele Polimeno, Stefano Messina, Gennaro Maresca, Salvatore Giordano, Giuseppe Biondi-Zoccai, Martino Pepe, Arturo Giordano","doi":"10.23736/S0026-4806.24.09236-X","DOIUrl":"10.23736/S0026-4806.24.09236-X","url":null,"abstract":"<p><p>Cardiovascular disease remains decade after decade a leading cause of mortality, morbidity and resource use globally as well as locally. We have had the opportunity of being involved in several iterative breakthroughs in invasive cardiovascular procedures, ranging from the advent of coronary stents to transcatheter mitral valve repair. Building up such extensive clinical and research experience, we hereby present 25 years of cardiovascular interventions at Pineta Grande Hospital and Casa di Salute S. Lucia, respectively in Castel Volturno, and S. Giuseppe Vesuviano, both in the Italian Campania region, where the same team of interventional cardiologists has managed to adopt and master several cardiovascular innovations for the benefit of thousands of patients. Our experience showcases the evolution of invasive cardiology, especially in diagnostic and therapeutic practices. Key highlights include advancements in coronary procedures, with the introduction of bare-metal stents, drug-eluting stents and drug-coated balloons, despite the setback of bioresorbable vascular scaffolds, as well as transcatheter aortic valve implantation and innovative approaches to mitral regurgitation. Furthermore, this overview scrutinizes procedural challenges, patient outcomes, and quality of life improvements, providing a rich tapestry of clinical experiences and research insights. It serves as a testament to the dynamic nature of interventional cardiology, offering a forward-looking perspective on future trends and technologies. We hope that this overview will prove an informative and insightful read for those seeking to understand the intricate journey of invasive cardiovascular care over the past decades and its trajectory into the future.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Male infertility: the role of lifestyle and environmental factors. 男性不育:生活方式和环境因素的作用。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-07-04 DOI: 10.23736/S0026-4806.24.09461-8
Anna Perri, Sabrina Bossio
{"title":"Male infertility: the role of lifestyle and environmental factors.","authors":"Anna Perri, Sabrina Bossio","doi":"10.23736/S0026-4806.24.09461-8","DOIUrl":"10.23736/S0026-4806.24.09461-8","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141500018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reappraisal of Pidotimod: an immunomodulatory agent with 30-year evidence. 重新评估匹多莫德:一种经过 30 年验证的免疫调节药物。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-07-17 DOI: 10.23736/S0026-4806.24.09391-1
Gian L Marseglia, Matteo Gelardi, Pierachille Santus, Giorgio Ciprandi
{"title":"Reappraisal of Pidotimod: an immunomodulatory agent with 30-year evidence.","authors":"Gian L Marseglia, Matteo Gelardi, Pierachille Santus, Giorgio Ciprandi","doi":"10.23736/S0026-4806.24.09391-1","DOIUrl":"10.23736/S0026-4806.24.09391-1","url":null,"abstract":"<p><p>Pidotimod (3-L-pyroglutamyl-L-thiaziolidine-4-carboxylic acid) is a synthetic dipeptide with immunomodulatory properties that is indicated for use in adults and children over 3 years of age with documented cell-mediated immunodepression during respiratory and urinary tract infections. Infections are associated with an immune response that helps fight pathogens. In this scenario, inflammatory events occur to improve the antimicrobial reaction. However, defective immunity and/or sustained inflammation may adversely affect the course of the infection. Thus, modulating immune function could be a valuable option in managing patients with infections. The multifaceted mechanism of action of Pidotimod enables it to modulate innate and adaptive immunity. Extensive evidence about Pidotimod, accumulated over the last 30 years, has provided much data on the prevention of recurrent respiratory infections in susceptible children and respiratory exacerbations in patients with chronic bronchitis. Recent studies provide interesting information on how Pidotimod affects the metabolomic profiles of patients with bronchiectasis, clinical and immunological outcomes of elderly patients with pneumonia, clinical and cellular changes in patients with allergic rhinitis and asthma, and beneficial effects on cytokines and humoral immunity in human immunodeficiency virus (HIV) patients. Preliminary experience suggests that Pidotimod can shorten the duration of COVID-19 infection and reduce clinical severity by modulating the immune response, as well as prevent vaccination-related adverse events. In conclusion, the immunomodulatory properties of Pidotimod indicate that it may be a valuable option in managing patients with respiratory infections and other immune-mediated disorders, including allergy, chronic obstructive pulmonary disease, and asthma.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of epidural anesthesia in labor pain management: a prospective observational study. 硬膜外麻醉在分娩镇痛中的疗效:一项前瞻性观察研究。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-03-26 DOI: 10.23736/S0026-4806.24.09189-4
Jiaolian Wang, Juyan Sun, Mengdie Chen
{"title":"Efficacy of epidural anesthesia in labor pain management: a prospective observational study.","authors":"Jiaolian Wang, Juyan Sun, Mengdie Chen","doi":"10.23736/S0026-4806.24.09189-4","DOIUrl":"10.23736/S0026-4806.24.09189-4","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis. 选择性 Janus 激酶-1 抑制剂 upatacitinib 对类风湿性关节炎疗效的多中心观察性研究。
Minerva medica Pub Date : 2024-08-01 DOI: 10.23736/S0026-4806.24.09409-6
Alberto Lo Gullo, Simone Parisi, Andrea Becciolini, Marino Paroli, Elena Bravi, Romina Andracco, Valeria Nucera, Francesca Ometto, Federica Lumetti, Antonella Farina, Patrizia Del Medico, Matteo Colina, Viviana Ravagnani, Palma Scolieri, Maddalena Larosa, Marta Priora, Elisa Visalli, Olga Addimanda, Rosetta Vitetta, Alessandro Volpe, Alessandra Bezzi, Francesco Girelli, Aldo Biagio Molica Colella, Rosalba Caccavale, Eleonora DI Donato, Giuditta Adorni, Daniele Santilli, Gianluca Lucchini, Eugenio Arrigoni, Ilaria Platè, Natalia Mansueto, Aurora Ianniello, Enrico Fusaro, Maria Chiara Ditto, Vincenzo Bruzzese, Dario Camellino, Gerolamo Bianchi, Francesca Serale, Rosario Foti, Giorgio Amato, Francesco DE Lucia, Ylenia Dal Bosco, Roberta Foti, Massimo Reta, Alessia Fiorenza, Guido Rovera, Antonio Marchetta, Maria C Focherini, Fabio Mascella, Simone Bernardi, Gilda Sandri, Dilia Giuggioli, Carlo Salvarani, Maria Ilenia DE Andres, Veronica Franchina, Francesco Molica Colella, Giulio Ferrero, Alarico Ariani
{"title":"Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis.","authors":"Alberto Lo Gullo, Simone Parisi, Andrea Becciolini, Marino Paroli, Elena Bravi, Romina Andracco, Valeria Nucera, Francesca Ometto, Federica Lumetti, Antonella Farina, Patrizia Del Medico, Matteo Colina, Viviana Ravagnani, Palma Scolieri, Maddalena Larosa, Marta Priora, Elisa Visalli, Olga Addimanda, Rosetta Vitetta, Alessandro Volpe, Alessandra Bezzi, Francesco Girelli, Aldo Biagio Molica Colella, Rosalba Caccavale, Eleonora DI Donato, Giuditta Adorni, Daniele Santilli, Gianluca Lucchini, Eugenio Arrigoni, Ilaria Platè, Natalia Mansueto, Aurora Ianniello, Enrico Fusaro, Maria Chiara Ditto, Vincenzo Bruzzese, Dario Camellino, Gerolamo Bianchi, Francesca Serale, Rosario Foti, Giorgio Amato, Francesco DE Lucia, Ylenia Dal Bosco, Roberta Foti, Massimo Reta, Alessia Fiorenza, Guido Rovera, Antonio Marchetta, Maria C Focherini, Fabio Mascella, Simone Bernardi, Gilda Sandri, Dilia Giuggioli, Carlo Salvarani, Maria Ilenia DE Andres, Veronica Franchina, Francesco Molica Colella, Giulio Ferrero, Alarico Ariani","doi":"10.23736/S0026-4806.24.09409-6","DOIUrl":"10.23736/S0026-4806.24.09409-6","url":null,"abstract":"<p><strong>Background: </strong>Upadacitinib (UPA) is a selective, reversible Janus kinase inhibitor (JAKi) approved for the treatment of RA. However, there is still no solid evidence on the long-term efficacy of UPA in treated patients. The purpose of this study was to determine the efficacy of UPA to obtain remission or low disease activity (LDA) in a series of UPA patients in patients with RA after 6 and 12 months of treatment in a real-world setting.</p><p><strong>Methods: </strong>A series of 111 consecutive patients treated with UPA in 23 rheumatology centers were enrolled. Personal history, treatment history and disease activity at baseline, after 6 and 12 months were recorded. Intention-to-treat (ITT) and per-protocol (PP) analyses assessed achievement of remission or LDA or defined as DAS28 <2.6 and ≤3.2, respectively. Logistic regression analysis examined the role of several independent factors on the reduction of disease activity after 6 months of treatment.</p><p><strong>Results: </strong>Of the initial group of 111 subjects at baseline, 86 and 29 participants completed clinical assessments at 6 and 12 months. According to ITT analysis, the rates of remission and LDA were 18% and 18% at 6 months and 31.5% and 12.5% at 12 months, respectively. PP analysis showed higher rates of remission and LDA at 6 (23.3% and 19.8%) and 12 months (55.2% and 20.7%). Results of multivariate logistic regression analysis indicated that a low DAS28 score (P=0.045) was the only predictor of achieving remission at 6 months. None of the baseline factors predicted remission/LDA at 6 months.</p><p><strong>Conclusions: </strong>RA patients treated with UPA achieved a significant rate of disease remission or LDA in a real-world setting. The 6-month response was found to depend only on the baseline value of DAS28, while it was not influenced by other factors such as disease duration, line of treatment or concomitant therapy with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or corticosteroids.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142396461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrogen sulfide affects aortic vasodilation in rats by mediating PI3K-Akt signaling pathway. 硫化氢通过介导 PI3K-Akt 信号通路影响大鼠主动脉血管扩张
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-01-15 DOI: 10.23736/S0026-4806.23.08955-3
Jingyi Sun, Jiajie Mei, Jingsi Zhang, Yu Lou, Shasha Jiang, Yang Li, Xiaodan Fu
{"title":"Hydrogen sulfide affects aortic vasodilation in rats by mediating PI3K-Akt signaling pathway.","authors":"Jingyi Sun, Jiajie Mei, Jingsi Zhang, Yu Lou, Shasha Jiang, Yang Li, Xiaodan Fu","doi":"10.23736/S0026-4806.23.08955-3","DOIUrl":"10.23736/S0026-4806.23.08955-3","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced bioavailability of cannabidiol via solubilization in edible oil blends. 通过在混合食用油中增溶提高大麻二酚的生物利用率。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-07-11 DOI: 10.23736/S0026-4806.24.09470-9
Francesco DI Pierro, Fazle Rabbani, Ayesha Kanwal, Areaba Shafiq, Hina Khokhar, Roohi Nigar, Amjad Khan, Alexander Bertuccioli, Massimiliano Cazzaniga, Luigina Guasti, Nicola Zerbinati
{"title":"Enhanced bioavailability of cannabidiol via solubilization in edible oil blends.","authors":"Francesco DI Pierro, Fazle Rabbani, Ayesha Kanwal, Areaba Shafiq, Hina Khokhar, Roohi Nigar, Amjad Khan, Alexander Bertuccioli, Massimiliano Cazzaniga, Luigina Guasti, Nicola Zerbinati","doi":"10.23736/S0026-4806.24.09470-9","DOIUrl":"10.23736/S0026-4806.24.09470-9","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application and handling of positive biological indicators in pressure steam sterilization. 压力蒸汽灭菌中阳性生物指标的应用和处理。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-02-07 DOI: 10.23736/S0026-4806.24.09183-3
Yajuan Wang, Yeyuan Chu, Jianli Fan, Chunfeng He, Minxia Gu, Xijuan Yang
{"title":"Application and handling of positive biological indicators in pressure steam sterilization.","authors":"Yajuan Wang, Yeyuan Chu, Jianli Fan, Chunfeng He, Minxia Gu, Xijuan Yang","doi":"10.23736/S0026-4806.24.09183-3","DOIUrl":"10.23736/S0026-4806.24.09183-3","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139699173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interplay between gender and pollution on the prognosis of resuscitated out-of-hospital cardiac arrest. 性别和污染对院外心脏骤停抢救预后的影响。
Minerva medica Pub Date : 2024-08-01 Epub Date: 2024-07-17 DOI: 10.23736/S0026-4806.24.09438-2
Janusz Sielski, Małgorzata Jóźwiak, Karol Kaziród-Wolski, Magdalena Wolska, Giovanni Chiariello, Carlo Gaudio, Giuseppe Biondi-Zoccai, Francesco Versaci, Zbigniew Siudak
{"title":"Interplay between gender and pollution on the prognosis of resuscitated out-of-hospital cardiac arrest.","authors":"Janusz Sielski, Małgorzata Jóźwiak, Karol Kaziród-Wolski, Magdalena Wolska, Giovanni Chiariello, Carlo Gaudio, Giuseppe Biondi-Zoccai, Francesco Versaci, Zbigniew Siudak","doi":"10.23736/S0026-4806.24.09438-2","DOIUrl":"10.23736/S0026-4806.24.09438-2","url":null,"abstract":"<p><strong>Background: </strong>Differences between men and women in prognosis after sudden pre-hospital out-of-hospital cardiac arrest (OHCA) have been described in many studies, but the interplay between gender and pollution have not been characterized in detail. We aimed at appraising the interplay between gender and pollution on the prognosis of OHCA.</p><p><strong>Methods: </strong>Details on patients with OHCA in whom return of spontaneous circulation was obtained and transferred to a large teaching hospital were obtained from the medical charts of the ambulance service and the Polish National Health Fund. Matching pollutant concentrations (PM 2.5, PM10, As, Ni, Cd, Pb) were obtained from the Polish National Environmental Protection Inspectorate.</p><p><strong>Results: </strong>Details on 948 resuscitated OHCA, 325 (34.3%) of them in women, and occurring between 2018 and 2021, were retrieved. Notably, OHCA in women was associated with significantly higher daily concentrations of PM10 (23.37 [17.09, 37.04] vs. 21.92 [16.32, 29.98] μg/m<sup>3</sup>, P=0.023) and PM2.5 (16.83 [11.87, 28.24] vs. 15.27 [11.64, 22.72] μg/m<sup>3</sup>, P=0.026), as well as heightened concentrations of Cd, daily (0.32 [0.19, 0.44] vs. 0.27 [0.17, 0.40] ng/m<sup>3</sup>, P=0.027) and over 30 days (0.34 [0.20, 0.44] vs. 0.29 [0.18, 0.43] ng/m<sup>3</sup>, P=0.027). Concurrently, OHCA in females was associated with lower daily temperatures on the day of the incident (8.40 [0.20, 15.40] vs. 9.90 [1.40, 15.90] °C, P=0.042). Despite these differences, survival at 30 days and 12 months was similar in women and men (both P>0.05).</p><p><strong>Conclusions: </strong>OHCA events with successful resuscitation in women occurred in concomitance with higher daily contaminant levels, yet short-term and long-term prognosis was similar in men and women. The interplay between gender and air pollution on OHCA outcomes requires further population-based studies.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信